Immatics Stock Today
| IMTX Stock | USD 10.79 0.79 6.82% |
|
|
Immatics is trading at 10.79 as of the 3rd of October 2023; that is -6.82 percent decrease since the beginning of the trading day. The stock's open price was 11.58. Immatics has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Immatics NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of August 2023 and ending today, the 3rd of October 2023. Please note, there could be an existing legal relationship between Immatics NV (IMTX) and ARYA Sciences Acquisition (ARYA). Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of July 2020 | Category Healthcare | Classification Health Care |
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. The company has 80.4 M outstanding shares of which 5.88 M shares are currently shorted by private and institutional investors with about 15.54 trading days to cover. More on Immatics NV
Moving against Immatics Stock
Follow Valuation Options Odds of Bankruptcy
Report 16th of November 2023
Immatics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Immatics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Immatics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Related Entity | ARYA (ARYA Sciences Acquisition) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Immatics report their recommendations after researching Immatics' financial statements, talking to executives and customers, or listening in on Immatics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Immatics NV. The Immatics consensus assessment is calculated by taking the average forecast from all of the analysts covering Immatics. Strong Buy5 Opinions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Piotroski F Score Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Immatics NV based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Immatics NV financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks. HealthyDetails
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Macroaxis Advice The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Immatics' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details BuyUndervalued | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Immatics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Immatics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Immatics' financial leverage. It provides some insight into what part of Immatics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immatics NV (IMTX) is traded on NASDAQ Exchange in USA. It is located in Paul-Ehrlich-Strasse 15, Tübingen, Germany, 72076 and employs 210 people. Immatics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 984.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immatics's market, we take the total number of its shares issued and multiply it by Immatics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Immatics NV conducts business under Biotechnology sector and is part of Health Care industry. The entity has 80.4 M outstanding shares of which 5.88 M shares are currently shorted by private and institutional investors with about 15.54 trading days to cover.
Immatics NV currently holds about 324.38 M in cash with 100.13 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.0.
Check Immatics Probability Of Bankruptcy
OwnershipImmatics secures a total of 80.4 Million outstanding shares. Immatics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Ownership Allocation
Check Immatics Ownership DetailsImmatics Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Immatics jumping above the current price in 90 days from now is close to 99%. The Immatics NV probability density function shows the probability of Immatics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Immatics has a beta of 0.5758. This usually indicates as returns on the market go up, Immatics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Immatics NV will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Immatics NV is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of Immatics to move above the current price in 90 days from now is close to 99 (This Immatics NV probability density function shows the probability of Immatics Stock to fall within a particular range of prices over 90 days) .
Immatics Historical Income Statement
Immatics NV Income Statement is one of the three primary financial statements used for reporting Immatics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Immatics NV revenue and expense. Immatics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Immatics Consolidated Income is fairly stable at the moment as compared to the past year. Immatics reported Consolidated Income of 37.51 Million in 2022. Earning Before Interest and Taxes EBIT is likely to rise to about 45.4 M in 2023, whereas Operating Expenses is likely to drop slightly above 127.8 M in 2023. View More FundamentalsImmatics Stock Against Markets
Picking the right benchmark for Immatics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Immatics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Immatics is critical whether you are bullish or bearish towards Immatics NV at a given time. Please also check how Immatics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Immatics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Immatics Corporate Management
Elected by the shareholders, the Immatics' board of directors comprises two types of representatives: Immatics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Immatics. The board's role is to monitor Immatics' management team and ensure that shareholders' interests are well served. Immatics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Immatics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anja BSc | Director Communications | Profile | |
| PHR MBA | Director HR | Profile | |
| Carsten MD | Chief Officer | Profile | |
| HansGeorg Rammensee | CoFounder Board | Profile | |
| Steffen Walter | Chief Officer | Profile | |
| Harpreet Singh | MD, CEO | Profile | |
| Edward Sturchio | G Sec | Profile |
How to buy Immatics Stock?
Before investing in Immatics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Immatics. To buy Immatics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Immatics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Immatics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Immatics NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Immatics NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Immatics NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Immatics Stock please use our How to Invest in Immatics guide.
Already Invested in Immatics NV?
The danger of trading Immatics NV is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Immatics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Immatics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Immatics NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in non-hispanic. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Immatics Stock analysis
When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Revenue Per Share 1.128 | Quarterly Revenue Growth (0.91) | Return On Assets (0.12) | Return On Equity (0.43) |
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.